S M Kobrin1, S J Goldstein, R F Shangraw
1Albert Einstein Medical Center, Kraftsow Division of Nephrology, Philadelphia, PA 19141.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Calcium carbonate tablets, used as supplements and for phosphate binding in kidney disease, were found ineffective in two cases. Product investigation revealed poor disintegration, dissolution, and clinical efficacy, prompting recommendations for healthcare providers.
Area of Science:
Background:
Observation:
Findings:
Implications: